WO2001048144A2 - Chambre de culture de cellules mammaliennes - Google Patents
Chambre de culture de cellules mammaliennes Download PDFInfo
- Publication number
- WO2001048144A2 WO2001048144A2 PCT/US2000/041800 US0041800W WO0148144A2 WO 2001048144 A2 WO2001048144 A2 WO 2001048144A2 US 0041800 W US0041800 W US 0041800W WO 0148144 A2 WO0148144 A2 WO 0148144A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- membrane
- cells
- cell culture
- impedance
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 18
- 210000004962 mammalian cell Anatomy 0.000 title description 4
- 239000007789 gas Substances 0.000 claims abstract description 10
- 238000012546 transfer Methods 0.000 claims abstract description 6
- 239000000919 ceramic Substances 0.000 claims description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052710 silicon Inorganic materials 0.000 claims description 8
- 239000010703 silicon Substances 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 description 90
- 239000012528 membrane Substances 0.000 description 63
- 210000004379 membrane Anatomy 0.000 description 62
- 230000036982 action potential Effects 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- 108091006146 Channels Proteins 0.000 description 22
- 230000001413 cellular effect Effects 0.000 description 22
- 238000012544 monitoring process Methods 0.000 description 21
- 239000000126 substance Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 229910001415 sodium ion Inorganic materials 0.000 description 14
- 210000000170 cell membrane Anatomy 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 238000001514 detection method Methods 0.000 description 8
- 108010082117 matrigel Proteins 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 108090000862 Ion Channels Proteins 0.000 description 7
- 102000004310 Ion Channels Human genes 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 6
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical compound CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 6
- 229960004623 paraoxon Drugs 0.000 description 6
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 5
- 239000004593 Epoxy Substances 0.000 description 5
- 229910052581 Si3N4 Inorganic materials 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 230000028161 membrane depolarization Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 238000002161 passivation Methods 0.000 description 5
- -1 polyethylene Polymers 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000000284 resting effect Effects 0.000 description 5
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000002858 neurotransmitter agent Substances 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 229910010293 ceramic material Inorganic materials 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 229920000557 Nafion® Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000009087 cell motility Effects 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000002847 impedance measurement Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002555 ionophore Substances 0.000 description 2
- 230000000236 ionophoric effect Effects 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000012771 pancakes Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002336 repolarization Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 108010053652 Butyrylcholinesterase Proteins 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 102100032404 Cholinesterase Human genes 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- YRIBGSCJIMXMPJ-UHFFFAOYSA-N butyrylcholine Chemical compound CCCC(=O)OCC[N+](C)(C)C YRIBGSCJIMXMPJ-UHFFFAOYSA-N 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000004635 cellular health Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/10—Petri dish
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/24—Gas permeable parts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/38—Caps; Covers; Plugs; Pouring means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
Definitions
- the present invention relates to a cell culture chamber 10. More
- the present invention relates to a cell culture chamber 10 utilizing a
- Biosensors sensors including biological materials employed to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were used to determine whether biological materials were Biosensors, sensors including biological materials employed to
- Biosensor detect and/or monitor an environment, offer several advantages.
- action potential parameters including action
- biosensors including live, intact
- hybrid biosensors have several commercially significant
- biosensors are particularly useful in detecting
- Biosensors may also supplement CBW and biological warfare agents.
- CBW chemical and biological warfare
- biosensor technology will eliminate, or at least greatly reduce, animal testing
- cellular membranes are modeled as having a constant capacitance
- the membrane further, thereby opening more channels, which admit more Na + ,
- the cell membrane can be made ready in less than a millisecond to
- Action potential rate refers to the frequency with
- Action potential which a cell produces an action potential (rapid depolarization).
- amplitude refers to the height of the peak depolarization that occurs in the course
- Action potential shape refers to the time course of the
- the present invention relates to a cell culture chamber 10 having a
- Figure 1 is a photograph showing the sensor array 16 chip bonded
- Figures 2 A-C are photomicrographs of the sensor array 16 chip
- Figure A is the test sensor
- Figure B is the test sensor
- FIGS 3 A and B are pictures showing the silicone applied to the
- Figure A shows a 2 ⁇ m electrode sensor array 16
- Figure B shows a 2 ⁇ m electrode sensor array 16
- Figure 4 is a picture showing the image of the entire cell culture
- Figure 5 is a side view of the preferred embodiment of the cell
- Figure 6 is another view of the preferred embodiment of the cell
- Figure 7 is a top view of the preferred embodiment of the cell culture
- Figure 8 is a photomicrograph at hNT neurons growing on the
- Figure 9 is a picture of dozens of mammalian cell culture chambers.
- the present invention provides a cell culture chamber 10
- sterile environment 12 it is meant that the environment or area
- the chamber 10 can include a
- cover 14 it is meant a device sufficient to maintain the sterility of
- the cover 14 is made of a clear material
- the cover 14 can also include a semi-permeable membrane. This membrane can be used to cover the cover 14 to cover 14 to cover 14 .
- This membrane can be used to cover the cover 14 to cover 14 .
- the present invention permits detection and monitoring of membrane
- the present invention provides an apparatus
- Matrigel matrix (Becton Dickinson Labware, Bedford, MA) were used to provide a
- the sensor array was first coated with poly-D-lysine to promote bonding of
- the sensor arrays were placed at an incline with
- Matrigel matrix was thawed overnight in a refrigerator, and then diluted to
- the sensor arrays could be stored for at least 2 months with one
- the present invention is useful in screening and assaying
- Cells are cultured within the medium according to known techniques.
- a layer of cells (Figure 8) adhere to the respective surfaces of the microelectrode
- the impedance is determined from this current signal.
- characteristics include the impedance of the individual cell (i.e., the combined cell
- the electrodes can also monitor the
- membrane potential produced by the cell such as neuronal action potentials.
- action potential parameters include, among others, action potential rate, action
- each of the microelectrodes is
- microelectrodes The specific size of the microelectrodes varies according to the
- the diameter of the cells to be monitored is preferably sized, the diameter of the cells to be monitored.
- the diameter of the cells to be monitored is preferably sized, the diameter of the cells to be monitored.
- microelectrodes is less than or equal to one-half the diameter of the cell to
- microelectrodes with diameters of about 4 to 20 ⁇ m have been utilized.
- this element can comprise a
- microelectrode and the reference electrode based on the signals detected with the
- the signal monitoring and processing means can be any signal monitoring and processing means.
- the sensors can also be operated to perform amperometric and
- the microelectrode has a known impedance Z elect . As known in the
- microelectrode is the resistance of the solution R so , n and the respective
- Z ref can be determined in a variety of ways. These values, as well as
- the resistance of the solution, R soln can be factored out, for example, by
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be any cell model.
- the cell can be
- models can include a flat, circular "pancake” (i.e., as a disk).
- Other models can include a
- synthesizer is used to generate both sine and cosine signals of a programmed
- the sine voltage signal is attenuated as needed and selectively applied to individual microelectrodes.
- the resulting signal is detected
- transimpedance stage which holds the large reference electrode at a
- control is used to amplify the voltage output of the transimpedance stage.
- amplified signal is multiplied in quadrature by the source signals and is low pass
- Quadrature multiplication allows for signal detection, for example, at the excitation
- a quadrature synthesizer generates both a
- the generated signals have a frequency of 1 kHz and an amplitude of 10 V peak to
- the sine wave is attenuated in this example, in a range from 0 to
- the attenuated signal is then selectively applied to particular
- microelectrodes In this example, an analog multiplexer is used to apply the
- the invention is not limited to the number of microelectrodes in the array or to the
- the resulting current is detected by a transimpedance amplifier
- the transimpedance amplifier outputs a signal, B sin ( ⁇ + ⁇ ).
- resistance R sense _ is applied across the input and output of the transimpedance
- the signal from the transimpedance amplifier is then amplified by an
- AGC automatic gain control
- the signal from the AGC amplifier is also mixed with the signal
- the system is calibrated with a known value
- phase ⁇ CAL of the calibration values are then determined as follows:
- ⁇ CAL arc tan [Y CAL /X CAL ]
- [X CAL 2 +Y CAL 2 ] 1/2
- ⁇ MEAS arc tan[X MEAS /Y MEAS ]
- [X MEAS 2 +Y MEAS 2 ] 1/2
- the detected values for X and Y are sampled with an analog to
- A/D converter installed in a PC.
- A/D analog digital
- processing means such as a PC, receives the detected signal through an (A/D)
- the output from the AGC amplifier could be A/D converted and input to a
- the signal monitoring and processing means obtains phase and magnitude
- processing means provides the capability of performing a spectral analysis to
- the system can perform spectral analysis of the
- the membrane which adheres to the respective microelectrodes.
- the membrane For example, the membrane
- microelectrodes can be monitored, based on various models of the cells.
- a test signal oscillator generates sine and cosine signals
- resulting current is detected using transimpedance amplifier and AGC amplifier.
- mixers are represented, respectively, by: (AB/2) cos [ ⁇ , F t+ ⁇ ]-(AB/2) cos [(2 ⁇ test + ⁇ IF )t+ ⁇ ](AB/2) sin [ ⁇ IF t+ ⁇ ]-(AB/2) sin [(2 ⁇ test
- the large reference electrode is then calculated in the manner described above.
- measurement in the time domain can be any measurement in the time domain.
- measurement in the time domain can be any measurement in the time domain.
- each impedance This can be accomplished, for example, by using a step function
- biocompatible conductive substance such as iridium, activated
- the substrate of the integrated device may be any organic compound. Additionally, the substrate of the integrated device may be any organic compound. Additionally, the substrate of the integrated device may be any organic compound.
- glass composed of a variety of materials, such as silicon, glass, metal, quartz, plastic, ceramic, polyethylene, or any other suitable type of polymer. It is noted that glass
- the passivation layer may comprise any suitable material, including low stress
- PECVD silicon nitride, silicon carbide, TEFLONTM, polyimide, ceramic, photoresist,
- Cloning cylinders housed in Petri dishes, are bonded to the
- the Petri dishes can comprise polystyrene,
- dishes may be bound to a chip formed in accordance with the invention using
- thermoplastic using chemical, thermal, or ultrasonic processes.
- thermal, thermal, or ultrasonic processes In this alternate
- bondwire connections can be eliminated by use of a substrate
- a connector such as an edge card connector or
- substrate area to be significantly larger than the active electrode area.
- plasma membrane depends on the distribution of ionic charge. Generally, the distribution of ionic charge determines the electric potential, or voltage. For
- the mobile particles carrying charge are
- the mobile particles are ions such as Na + , K + ,
- Nafion acts as a cation exchange membrane (Brazell, et al.,
- the concentration of the parent bioagent molecule can be
- gated channels Two classes of gated channels are of
- channels are not particular to neurons: they are also found in many other types of
- One goal of the present invention is to augment semiconductor
- complex molecules with a membrane is to catalize or inhibit a reaction such as the
- neurotoxins and molecules of biological warfare can be detected by immobilizing antibodies and/or enzymes on the surface of an ion-selective membrane, by
- organophosphates inhibit the reaction mechanism causing
- cholinesterase enzymes these can be used to monitor the presence of Paraoxon.
- the membranes must adhere well to the silicon surface to prevent detachment of
- membranes include, but are not limited to,
- enzymes can be immobilized on the membrane surface that
- organophosphorus compounds such as Paraoxon is to monitor the inhibition of the
- Membrane adhesion is a critical factor and must be
- Membranes can be deposited using a set of micropipettes accurate
- surfaces can print with +/-5 micron alignment and 25 to 50 micron minimum
- a mammalian cell culture chamber 10 with an integrated silicon
- the chamber 10 has a
- cover 14 that allows free transfer of metabolic gases, minimizes medium
- test stations microscope, experimental setup, laminar flow hood, etc.
- silicon sensor array 16 is a general purpose device which may be modified to
- the sensor chips are packaged in a ceramic 100-pin pin grid array
- the ceramic package body offers
- the thermal properties of ceramic material provide temperature stability when used for
- the ceramic material acts as a thermal buffer minimizing temperature
- Epoxy Patch 1 C (Dexter Corporation)
- the bonded ceramic packages are heated to
- Epoxy Patch is carefully applied to the hot packages with
- a small, sterile cloning cylinder (Fisher Scientific, Chicago, IL) is placed over this
- the chambers 10 allowed free exchange of metabolic gases
- the chambers 10 are
- Keese C.R. et al., "A Whole Cell Biosensor Based on Cell-Substrate Interactions," Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Vol. 12, No. 2, (1990);
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU55155/01A AU5515501A (en) | 1999-11-02 | 2000-11-02 | Mammalian cell culture chamber |
US10/129,248 US6852525B1 (en) | 1999-11-02 | 2002-11-02 | Mammalian cell culture chamber |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16347099P | 1999-11-02 | 1999-11-02 | |
US60/163,470 | 1999-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001048144A2 true WO2001048144A2 (fr) | 2001-07-05 |
WO2001048144A3 WO2001048144A3 (fr) | 2001-12-20 |
Family
ID=22590153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/041800 WO2001048144A2 (fr) | 1999-11-02 | 2000-11-02 | Chambre de culture de cellules mammaliennes |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5515501A (fr) |
WO (1) | WO2001048144A2 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005168494A (ja) * | 2003-11-17 | 2005-06-30 | Hitachi Ltd | 細胞培養容器、及び培養細胞 |
JP2005312343A (ja) * | 2004-04-28 | 2005-11-10 | Hitachi Ltd | 観察用容器及び培養用容器,培養細胞 |
EP1541670A4 (fr) * | 2002-08-26 | 2008-07-23 | Japan Science & Tech Agency | Microchambre destinee a la culture de cellules nerveuses |
WO2010148392A1 (fr) | 2009-06-19 | 2010-12-23 | University Of Maryland Baltimore County | Détection non invasive de paramètres de bioprocédés |
WO2011000572A1 (fr) | 2009-07-02 | 2011-01-06 | Patenthandel Portfoliofonds I Gmbh & Co. Kg | Procédé et dispositif permettant de mettre en évidence des effets biologiques à long terme dans des cellules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5810725A (en) * | 1993-04-16 | 1998-09-22 | Matsushita Electric Industrial Co., Ltd. | Planar electrode |
US5563067A (en) * | 1994-06-13 | 1996-10-08 | Matsushita Electric Industrial Co., Ltd. | Cell potential measurement apparatus having a plurality of microelectrodes |
US5981268A (en) * | 1997-05-30 | 1999-11-09 | Board Of Trustees, Leland Stanford, Jr. University | Hybrid biosensors |
-
2000
- 2000-11-02 AU AU55155/01A patent/AU5515501A/en not_active Abandoned
- 2000-11-02 WO PCT/US2000/041800 patent/WO2001048144A2/fr active Application Filing
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1541670A4 (fr) * | 2002-08-26 | 2008-07-23 | Japan Science & Tech Agency | Microchambre destinee a la culture de cellules nerveuses |
JP2005168494A (ja) * | 2003-11-17 | 2005-06-30 | Hitachi Ltd | 細胞培養容器、及び培養細胞 |
JP2005312343A (ja) * | 2004-04-28 | 2005-11-10 | Hitachi Ltd | 観察用容器及び培養用容器,培養細胞 |
WO2010148392A1 (fr) | 2009-06-19 | 2010-12-23 | University Of Maryland Baltimore County | Détection non invasive de paramètres de bioprocédés |
EP2443224A4 (fr) * | 2009-06-19 | 2014-10-22 | Univ Maryland | Détection non invasive de paramètres de bioprocédés |
WO2011000572A1 (fr) | 2009-07-02 | 2011-01-06 | Patenthandel Portfoliofonds I Gmbh & Co. Kg | Procédé et dispositif permettant de mettre en évidence des effets biologiques à long terme dans des cellules |
Also Published As
Publication number | Publication date |
---|---|
AU5515501A (en) | 2001-07-09 |
WO2001048144A3 (fr) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6852525B1 (en) | Mammalian cell culture chamber | |
US6051422A (en) | Hybrid biosensors | |
Xu et al. | Cell-based biosensors based on light-addressable potentiometric sensors for single cell monitoring | |
Pancrazio et al. | Development and application of cell-based biosensors | |
CN2372689Y (zh) | 电流型生物传感器 | |
Ding et al. | Trends in cell-based electrochemical biosensors | |
Mamouni et al. | Interdigitated microelectrode-based microchip for electrical impedance spectroscopic study of oral cancer cells | |
EP3464551B1 (fr) | Détection d'agents infectieux viables dans un échantillon de fluide et sensibilité des agents infectieux à des agents anti-infectieux | |
US20060160144A1 (en) | Sensor arrangement, device and method for testing active substances and/or active sites from a pharmacological point of view using an amperometer and/or potentiometer | |
US20040040868A1 (en) | Microfabricated sensor arrays for multi-component analysis in minute volumes | |
Bao et al. | Recent advances in electric analysis of cells in microfluidic systems | |
JPH11503316A (ja) | 測定装置 | |
EP1230539A1 (fr) | Reseau de capteurs microscopiques multisites a circuits d'analyse et de commande integres | |
Yang et al. | Biosensors and their Applications | |
Mross et al. | Integrated multi-sensor system for parallel in-situ monitoring of cell nutrients, metabolites, cell density and pH in biotechnological processes | |
Thompson et al. | Biosensors and bioprobes | |
Urban et al. | Performance of integrated glucose and lactate thin-film microbiosensors for clinical analysers | |
JP2009544947A (ja) | 細胞に関するオンライン測定のための装置 | |
WO2001048144A2 (fr) | Chambre de culture de cellules mammaliennes | |
Wagner et al. | Light-addressable potentiometric sensors (LAPS): recent trends and applications | |
Eiler et al. | Application of a thin-film transistor array for cellular-resolution electrophysiology and electrochemistry | |
Borghol et al. | Monitoring of E. coli immobilization on modified gold electrode: A new bacteria-based glucose sensor | |
US20050227139A1 (en) | Device and methods for carring out electrical measurements on membrane bodies | |
WO2004046707A1 (fr) | Reseau microscopique de detecteurs multisites a circuit de commande et d'analyse integre | |
Primiceri et al. | Development of EIS cell chips and their application for cell analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10129248 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |